product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
ATRX (D1N2E) Rabbit mAb
catalog :
14820
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D1N2E
reactivity :
human
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...; fig 6b
Brosnan Cashman J, Yuan M, Graham M, Rizzo A, Myers K, Davis C, et al. ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner. PLoS ONE. 2018;13:e0204159 pubmed publisher
Barroso González J, García Expósito L, Hoang S, Lynskey M, Roncaioli J, Ghosh A, et al. RAD51AP1 Is an Essential Mediator of Alternative Lengthening of Telomeres. Mol Cell. 2019;76:11-26.e7 pubmed publisher
Mason Osann E, Dai A, Floro J, Lock Y, Reiss M, Gali H, et al. Identification of a novel gene fusion in ALT positive osteosarcoma. Oncotarget. 2018;9:32868-32880 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.